Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (SHA:603707)
China · Delayed Price · Currency is CNY 8.40
-0.13 (-1.52%)
May 20, 2026, 11:29 AM CST
SHA:603707 Revenue
Nanjing King-Friend Biochemical Pharmaceutical had revenue of 928.66M CNY in the quarter ending March 31, 2026, with 4.91% growth. This brings the company's revenue in the last twelve months to 4.03B, up 6.03% year-over-year. In the year 2025, Nanjing King-Friend Biochemical Pharmaceutical had annual revenue of 3.99B with 1.71% growth.
Revenue (ttm)
4.03B
Revenue Growth
+6.03%
P/S Ratio
3.42
Revenue / Employee
2.97M
Employees
1,360
Market Cap
13.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.99B | 67.09M | 1.71% |
| Dec 31, 2024 | 3.92B | -7.80M | -0.20% |
| Dec 31, 2023 | 3.93B | 218.67M | 5.89% |
| Dec 31, 2022 | 3.71B | 26.03M | 0.71% |
| Dec 31, 2021 | 3.69B | 771.81M | 26.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition